Evidence map›Paper›PMID 34724350›Full record

ArticleTransboundary and emerging diseases2022

Large-scale study on virological and serological prevalence of SARS-CoV-2 in cats and dogs in Spain.

Sandra Barroso-Arévalo, Alberto Barneto, Ángel Manuel Ramos, Belén Rivera, Rocío Sánchez, Lidia Sánchez-Morales, Marta Pérez-Sancho, Aránzazu Buendía, Elisa Ferreras, Juan Carlos Ortiz-Menéndez and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Spike destabilization attenuates Mink Cluster 5 SARS-CoV-2.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. SARS-CoV-2 Seroprevalence Studies in Pets, Spain.Emerging infectious diseases · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Sandra Barroso-ArévaloVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0001-6852-2487
Alberto BarnetoVeterinary Clinic Ayavet, Madrid, Spain.
Ángel Manuel RamosInterdisciplinary Mathematics Institute, Complutense University of Madrid, Madrid, Spain.
Belén RiveraVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Rocío SánchezVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Lidia Sánchez-MoralesVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Marta Pérez-SanchoVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Aránzazu BuendíaVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Elisa FerrerasSaBio Instituto de Investigación en Recursos Cinegéticos IREC (UCLM-CSIC), Ciudad Real, Spain.
Juan Carlos Ortiz-MenéndezAssociation of Municipal Veterinarians (AVEM), Madrid, Spain.
Inmaculada MorenoMicrobial Immunology Unit, National Center for Microbiology, Carlos III Health Institute, Madrid, Spain.
Consuelo SerresDepartment of Animal Medicine and Surgery, Faculty of Veterinary, Complutense University of Madrid, Madrid, Spain.
Carmen VelaIngenasa, Madrid, Spain.
María Ángeles RisaldeResearch Group in Animal Health and Zoonoses (GISAZ), Department of Anatomy and Comparative Pathology, Faculty of Veterinary, University of Cordoba, Andalusia, Spain.
Lucas DomínguezVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
José M Sánchez-VizcaínoVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0002-1502-8968
Universidad Complutense de Madrid · ESAdasa (Spain) · ESAyuntamiento de Madrid · ESInstituto de Investigación en Recursos Cinegéticos · ESInstituto de Salud Carlos III · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESVeterinarians Without Borders · US

Funding

Institute of Health Carlos III (ISCIII) COV20/01385
6 · The paper itself

Abstract

The disease produced by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is currently one of the primary concerns worldwide. Knowing the zoonotic origin of the disease and that several animal species, including dogs and cats, are susceptible to viral infection, it is critical to assess the relevance of pets in this pandemic. Here, we performed a large-scale study on SARS-CoV-2 serological and viral prevalence in cats and dogs in Spain in order to elucidate their role and susceptibility. Samples from animals in contact with COVID-19 positive people and/or compatible symptoms (n = 492), as well as from random animals (n = 1024), were taken. Despite the large number of animals analyzed, only 12 animals (eight dogs and four cats), which represents 0.79% of the total analyzed animals (n = 1516), were positive for viral SARS-CoV-2 RNA detection by reverse transcription quantitative PCR (RT-qPCR) in which viral isolation was possible in four animals. We detected neutralizing antibodies in 34 animals, four of them were also positive for PCR. This study evidences that pets are susceptible to SARS-CoV-2 infection in natural conditions but at a low level, as evidenced by the low percentage of positive animals detected, being infected humans the main source of infection. However, the inclusion of animals in the surveillance of COVID-19 is still recommended.

Indexed as

Cat DiseasesCOVID-19Dog DiseasesAnimalsCatsDogsHumansPrevalenceRNA, ViralSARS-CoV-2SpainRNA, Viralcatsdogsneutralizing antibodiesRT-qPCRSARS-CoV-2viral isolation

Identifiers

PMID34724350
PMCPMC8661836
OpenAlexW3209846033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.